Some people may need a few weeks to taper off, while others may require several months to gradually lower their dosage
The mean oral bioavailability of semaglutide reached 0.4% to 1.0% when co-formulated with 300 mg of SNAC in humans [19]
Semaglutide base may harm the fetus, and patients planning pregnancy should stop it at least 2 months before conception
Further research found that after implementing intervention measures, the relative expression level of CYP19A1 showed a clear doseresponse relationship, that is, with the increase of intervention dose, its expression level correspondingly increased (Figure 5D and E)
However, some individuals may experience: Injection site reactions such as mild redness, itching, or swelling Water retention or mild fluid buildup, particularly in the early weeks Joint discomfort or stiffness, which often resolves as the body adjusts Tingling or numbness in the hands or feet (less common) Elevated blood glucose levels in individuals predisposed to insulin resistance It is worth noting that tesamorelin should not be used by individuals with active cancer, those who are pregnant, or patients with hypersensitivity to its components
